Changes in prostate cancer screening practice by blood PSA testing between 2011 and 2017, a French population-based study

Objective The aim of the study was to determine the trend of first blood prostate-specific antigen (PSA) test prescription in France between 2011 and 2017, based on the assumption that prostate cancer (PCa) screening is expected to decline over the years.Method Using a representative sample of the French population from the French Health Insurance database, we identified 50–52-year-old men without PCa and without any blood PSA test in the five...